Drug Intelligence is your strategic partner through the lifecycle of your therapeutic product and portfolio
Market Planning
Epidemiology, patient & treatment flow, competitive landscape, specialist level data accurate market forecast assumptions.
Market Access
Real-World longitudinal data for gap analysis, payer awareness and submissions.
Market Preparation
Assess the gaps and understand actual clinical experience on existing treatments.
Product Tracking
Post-approval early uptake monitoring and payer detail in target patient segments.
Market Watch
Quarterly reporting of class & products by indication and line of treatment
Drivers for Uptake
Clinical and other factors impacting early adoption
Competitive Share
Quarterly tracking of patient or product share and competitor activity.
Timely Impact
Identify patient characteristics and clinical gaps that are creating barriers to growth.
RWE Publications
Reflect real-world, real-practice product experience.
